Compare BioNano Genomics Inc (BNGO) vs First Trust Cloud Computing ETF (SKYY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs First Trust Cloud Computing ETF — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.66M), while First Trust Cloud Computing ETF trades at $162.57. The key difference: First Trust Cloud Computing ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | SKYY | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | — |
52-Week High | $4.92 | $161.09 |
52-Week Low | $1.06 | $104.16 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.195, up 3.02% today, with a bullish technical signal from moving averages but a neutral oscillator stance. The company shows improving financial trends, with net losses narrowing to -$26.40M in 2025 from -$232M in 2023, and recent earnings beats. Revenue stabilized around $29M, while cash flow trends indicate reduced operational cash burn. Analyst sentiment is positive, with 57% buy ratings.
The outlook for BNGO hinges on sustaining revenue growth and achieving profitability, supported by strategic hires and debt retirement. Key risks include persistent negative margins and high cash burn. With a low P/S of 0.31, the stock offers value if execution improves, but investors face volatility from operational challenges and competitive pressures.
SKYY (First Trust Cloud Computing ETF) trades at $162.56, up 1.11% with strong technical momentum as moving averages signal bullish sentiment. The ETF provides diversified exposure to cloud infrastructure, software, and AI companies, benefiting from secular trends in digital transformation. Recent news highlights institutional interest in cloud computing ETFs as AI adoption accelerates.
The outlook remains positive given cloud migration trends and AI infrastructure investments, though overbought technical indicators suggest potential near-term consolidation. Key risks include regulatory developments in Europe's tech sovereignty initiatives and competitive pressures in the cloud computing sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About First Trust Cloud Computing ETF
The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →
